The future of biopharma
Shifts in how diseases are diagnosed and prevented, custom treatments, curative therapies, digital therapeutics, and precision intervention could upend current business models in biopharma. Deloitte's Five forces to 2040 Prevention and early detection Customized treatments - interventions for very...
Source: deloitte.com
Validation of Claims-Based Algorithms to Identify Patients with Psoriasis - PubMed Pharmacoepidemiology and drug safety.
Claims-based algorithms based on a combination of PsO diagnosis codes and dispensing for PsO-specific treatments had a moderate-to-high PPV. These algorithms can serve as a useful tool to identify patients with PsO in future real-world data pharmacoepidemiologic studies. This article is protected by...
Source: nih.gov
UCL cancer policy update
“Because of the complexity of delivering better cancer care and the dynamics of NHS funding and introducing better practices in the health service there is a strong case for developing new cancer strategies for all the UK nations for the 2020s. Britain could also benefit from leading an independent...
Source: ucl.ac.uk
Milasen - a drug developed for a single patient.
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease | NEJM: Summary Genome sequencing is often pivotal in the diagnosis of rare diseases, but many of these conditions lack specific treatments. We describe how molecular diagnosis of a rare, fatal neurodegenerative condition led to the...
Source: nejm.org
IBM Pitched Its Watson Supercomputer as a Revolution in Cancer Care. It's Nowhere Close - Slashdot: "IBM began selling
IBM Pitched Its Watson Supercomputer as a Revolution in Cancer Care. It's Nowhere Close - Slashdot: "IBM began selling Watson to recommend the best cancer treatments to doctors around the world three years ago. But is it really doing its job? Not so much. An investigation by Stat found that the supercomputer...
Source: slashdot.org
Is Exenatide a Treatment for Parkinson’s Disease? Athauda, Dilan. Wyse, Richard. Brundin, Patrik. Foltynie, Thomas. Journal
Is Exenatide a Treatment for Parkinson’s Disease? Athauda, Dilan. Wyse, Richard. Brundin, Patrik. Foltynie, Thomas. Journal of Parkinson's Disease. "There is growing interest in the use of glucagon-like peptide-1
agonists as treatments for Parkinson’s disease following the recent
publication...
Source: iospress.com
Sudden Death Rates Drop in Trial Participants with Heart Failure: By Amy Orciari Herman Edited by Susan Sadoughi, MD,
Sudden Death Rates Drop in Trial Participants with Heart Failure: By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM
Rates of sudden death in patients with heart failure declined significantly over the past two decades, finds a study in the New England...
Source: jwatch.org
Diagnosis and management of dementia with Lewy bodies
"The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. The revised DLB consensus criteria now distinguish clearly between clinical features...
Source: neurology.org
Paediatric IBD patients not meeting recommended calcium & vitamin D intake: The study found that only 26.6% and 21.3% of
Paediatric IBD patients not meeting recommended calcium & vitamin D intake: The study found that only 26.6% and 21.3% of sufferers were achieving the current recommended intake of calcium and vitamin D respectively. Achieving the correct levels of calcium and vitamin D is essential for developing children,...
Source: eurekalert.org
UK's first proton beam machine arrives at Newport clinic - BBC News: The UK's first high-energy proton beam machine will
UK's first proton beam machine arrives at Newport clinic - BBC News: The UK's first high-energy proton beam machine will offer treatments next year, the firm behind it says.
Source: bbc.co.uk
NEJM Journal Watch Psychiatry Top Stories of 2016: On behalf of the editors of NEJM Journal Watch Psychiatry , I am pleased
NEJM Journal Watch Psychiatry Top Stories of 2016: On behalf of the editors of NEJM Journal Watch Psychiatry , I am pleased to present the Psychiatry Top Stories of 2016.
The selection of the 10 best stories was, as always, difficult, with more than 200 summaries published in the past year that inform...
Source: jwatch.org
Doctors Overlook Lucrative Procedures When Naming Unwise Treatments : In the "Choosing Wisely" campaign, medical specialty
Doctors Overlook Lucrative Procedures When Naming Unwise Treatments : In the "Choosing Wisely" campaign, medical specialty societies have published lists of procedures that doctors and patients should consider skeptically. But some groups overlooked their own dubious...
Source: khn.org
Another child with cancer endangered by alternative medicine: Yesterday, I wrote about the winner of the Nobel Prize in
Another child with cancer endangered by alternative medicine: Yesterday, I wrote about the winner of the Nobel Prize in Physiology or Medicine, Youyou Tu, who, after screening 2,000 herbal treatments from traditional Chinese medicine (TCM) for anti-malaria activity, finally discovered Artemisinin. She...
Source: scienceblogs.com
Study's message to recovering alcoholics: Quit smoking to stay sober: Adult smokers with a history of problem drinking who
Study's message to recovering alcoholics: Quit smoking to stay sober: Adult smokers with a history of problem drinking who continue smoking are at a greater risk of relapsing three years later compared with adults who do not smoke. While treatments for alcohol abuse traditionally require concurrent treatment...
Source: eurekalert.org
FDA Approves Two New Treatments for Diabetes NEJM Journal Watch.
FDA Approves Two New Treatments for Diabetes NEJM Journal Watch.
Source: jwatch.org
RSS feed